Brief: PYC Therapeutics Announces A$74.6 Million Extension Of Cash Runway
10/04/2024 11:07
April 10 (Reuters) - PYC Therapeutics Ltd PYC.AX :
* A$74.6 MILLION EXTENSION OF CASH RUNWAY
* GOT BINDING COMMITMENTS FOR FULL A$74.6 MILLION
CONTEMPLATED
UNDER ACCELERATED NON-RENOUNCEABLE ENTITLEMENT OFFER
* FUNDS RAISED WILL ALLOW CO TO DELIVER MULTIPLE HUMAN
SAFETY AND
EFFICACY READ-OUTS ACROSS CO'S DRUG DEVELOPMENT PIPELINE
Further company coverage: PYC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PYC Therapeutics
See all newsAustralia's PYC Therapeutics rises on EU orphan drug status
Brief: PYC Therapeutics Posts HY Revenues From Ordinary Activities A$11.0 Million
Brief: PYC Therapeutics Announces Raising Up To A$653 Million
Brief: PYC Therapeutics Seeks Trading Halt
Brief: PYC Therapeutics Says Rohan Hockings Re-Appointed As Managing Director